Wedzony K, Fijał K, Chocyk A
Institute of Pharmacology, Polish Academy of Sciences, Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, 12 Smetna Street, 31-343 Kraków, Poland.
J Physiol Pharmacol. 2005 Jun;56(2):205-21.
Malfunction of glutamatergic neurotransmission in postnatal period is considered to be a risk factor for development of schizophrenia. Thus, the present study investigates the impact of NMDA receptor blockade in the postnatal period on the density of tyrosine hydroxylase immunoreactive axonal arbors in the rat medial prefrontal cortex. Behavioral experiments revealed that adult rats (60 days old) treated in the postnatal period with a competitive antagonist of NMDA receptors, CGP 40116 (1.25 mg/kg on days 1, 3, 6, 9; 2.5 mg/kg on days 12, 15, 18; and finally 5 mg/kg on day 21, all injections s.c.), showed enhancement of the locomotor activity stimulated by quinpirole (0.3 mg/kg s.c.) and amphetamine (0.5 mg/kg s.c.), which suggests development of functional supersensitivity of dopaminergic systems. It has been found that CGP 40116, given in postnatal period decreased the density of tyrosine hydroxylase immunoreactive axonal arbors in the medial prefrontal cortex of adult animals. The decrease was observed in superficial (II/III) and deep (V/VI) layers of the medial prefrontal cortex, while the average length of tyrosine hydroxylase immunoreactive axonal arbors was increased in both superficial and deep cortical layers. Changes in the density of tyrosine hydroxylase immunoreactive axonal arbors have not been followed by a significant decrease in the content of tyrosine hydroxylase protein measured by Western blot. Thus, NMDA receptor blockade in the early period of life evokes changes in architecture of tyrosine hydroxylase immunoreactive axonal arbors and that malfunction of glutamatergic neurotransmission, in early period of life may produce anatomical changes which resemble those observed in the brains of schizophrenics.
出生后谷氨酸能神经传递功能障碍被认为是精神分裂症发病的一个风险因素。因此,本研究调查了出生后NMDA受体阻断对大鼠内侧前额叶皮质中酪氨酸羟化酶免疫反应性轴突分支密度的影响。行为实验表明,出生后用NMDA受体竞争性拮抗剂CGP 40116(第1、3、6、9天为1.25mg/kg;第12、15、18天为2.5mg/kg;最后在第21天为5mg/kg,均皮下注射)处理的成年大鼠(60日龄),对喹吡罗(0.3mg/kg皮下注射)和苯丙胺(0.5mg/kg皮下注射)刺激的运动活动增强,这表明多巴胺能系统出现了功能性超敏反应。研究发现,出生后给予CGP 40116可降低成年动物内侧前额叶皮质中酪氨酸羟化酶免疫反应性轴突分支的密度。在内侧前额叶皮质的浅层(II/III)和深层(V/VI)均观察到了这种降低,而酪氨酸羟化酶免疫反应性轴突分支的平均长度在浅层和深层皮质层均增加。酪氨酸羟化酶免疫反应性轴突分支密度的变化并未伴随着通过蛋白质印迹法测得的酪氨酸羟化酶蛋白含量的显著降低。因此,生命早期的NMDA受体阻断会引起酪氨酸羟化酶免疫反应性轴突分支结构的变化,并且生命早期谷氨酸能神经传递功能障碍可能会产生类似于在精神分裂症患者大脑中观察到的解剖学变化。